GSK plc (GSK) said on Monday that its application for extending the use of its respiratory syncytial virus (RSV) vaccine ...

London: GSK plc has announced that the US Food and Drug Administration (FDA) has accepted for review an application to extend ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

Shifts in RSV testing methodology, which were accelerated by changes related to the COVID-19 pandemic, mirror shifts seen in ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa's private sector but not yet in public clinics. The country's advisory group on ...

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...

Respiratory syncytial virus (RSV) is a common, contagious virus that affects your respiratory system. It spreads easily and leads to cold-like symptoms such as a runny nose and cough. Most people ...

Cases of RSV, a respiratory virus, fell amid pandemic shutdowns last year. Now it’s reemerging in the South, and children may be more vulnerable. June 11, 2021.

RSV symptoms include cough and it can be severe in babies and toddlers. There is no vaccine or treatment. All usually begin as upper respiratory infections, making it difficult for parents to know ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

As COVID-19 recedes, the respiratory disease RSV is spiking in the southern U.S. Here's why RSV is surging during summer 2021.